Skip to main content
Figure 5 | Breast Cancer Research

Figure 5

From: Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2

Figure 5

Activity of adoptively transferred spleen cells from mice vaccinated with empty vector (pVAX1) or with HuRT-DNA against the subcutaneous growth of syn-HER2 cancer cells (Winn test). A 40:1 ratio of spleen to cancer cells was used. Data are mean ± SEM of five mice per group. *P < 0.05 vs. pVAX1-vaccinated group by Student’s t-test. HuRT, chimeric human/rat HER2 plasmid electroporated vaccine.

Back to article page